We are live on ! Find out more

83 hedge funds and large institutions have $65.3M invested in iBio in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.04%0.04% (-0%)

4% less capital invested

Capital invested by funds: $68.4M → $65.3M (-$3.04M)

9% less funds holding

Funds holding: 9183 (-8)

36% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 22

40% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 30

42% less call options, than puts

Call options by funds: $2.13M | Put options by funds: $3.67M

Holders
83
Holders Change
-8
Holders Change %
-8.79%
% of All Funds
1.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
18
Reduced
30
Closed
22
Calls
$2.13M
Puts
$3.67M
Net Calls
-$1.54M
Net Calls Change
-$757K

IBIO Hedge Fund Activity: Q2 2021 in Review

83 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q2 2021, worth a combined $65.3M — down 4.4% from $68.4M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of IBIO and 14 opened new positions — a net loss of 8 holders — while 30 trimmed existing stakes and 18 added.

The largest buyer was State Street, adding an estimated $1.33M. The largest seller was Principal Financial Group, cutting an estimated $1.5M.

  • 83 institutional investors held iBio (IBIO) as of Q2 2021, down from 91 in Q1 2021.
  • Funds reported $65.3M of iBio stock for Q2 2021, down 4.4% quarter-over-quarter.
  • 14 funds opened new iBio positions in Q2 2021 and 22 closed out, a net change of -8 holders.
  • The largest iBio buyer in Q2 2021 was State Street, an estimated $1.33M added.
  • The largest iBio seller in Q2 2021 was Principal Financial Group, an estimated $1.5M sold.

Based on aggregated 13F filings for Q2 2021.